-+ 0.00%
-+ 0.00%
-+ 0.00%

Genius Venture Capital sells PRIMACYT stake to founder and other shareholders

PUBT·11/11/2026 16:45:22
Listen to the news
Genius Venture Capital sells PRIMACYT stake to founder and other shareholders
  • Genius Venture Capital sold its stake in PRIMACYT Cell Culture Technology to founder Dieter Runge and other shareholders.
  • The transaction was completed upon receipt of payment, according to the Nov. 11, 2026, update.
  • PRIMACYT, an international laboratory and contract research business specializing in cell-based testing systems, first received funding from the investor in 2004.
  • Runge will continue leading PRIMACYT, which remains independent and plans further international expansion and new testing systems.
  • The sale frees up capital for new investments in innovative technology companies in Mecklenburg-Western Pomerania.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genius Venture Capital GmbH published the original content used to generate this news brief on November 11, 2026, and is solely responsible for the information contained therein.